On Thursday, Hims & Hers Health Inc. (NYSE:HIMS) announced Thursday an expansion of its weight loss specialty by enabling ...

Icon's rollout of ChartCheck Adaptive has progressed steadily since November, with clinical teams reporting positive early experiences as the technology has been incorporated across multiple centres.

Omnicell delivers solid fourth quarter 2025 financial results. Announces major step toward autonomous medication management with the launch of its next generation dispensing syste ...

If I invested $10,000 and couldn’t touch it for 10 years, these are the ASX shares I would trust to quietly compound. The ...

Hinge Health, Inc. (NYSE:HNGE) Q4 2025 Earnings Call Transcript February 10, 2026 Hinge Health, Inc. beats earnings expectations. Reported EPS is $0.3797, expectations were $0.04. Operator: Ladies and ...

Congress has passed — and President Trump has signed — the annual spending bill for the Department of Health and Human ...

When a medication doesn’t exist in the right dose, form or formulation, patients are left with few options – a challenge in rural areas like La Plata County. That gap is filled by compounding ...

A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.

COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online ...

A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency’s decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the drug ...

Shares of Microsoft and ServiceNow are trading at attractive prices after the steep sell-off in software stocks.

Amazon Pharmacy to Offer Same-Day Delivery to 2,000 More Communities in 2026 ...